AskY Therapeutics
Owings Mills, US · Founded 2022 · Delaware corporation
Founders & leadership
DW
Dan WatkinsNamed on SEC filing
AK
Alexander KrupnickNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$740K disclosed across 2 rounds · 2022–2024
▶$460KraisedJun 2024 · 12 investors · BiotechnologyRule 506(b)
▶$460KraisedJun 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander KrupnickExecutive Officer, Director
- Dan WatkinsExecutive Officer, Director
- John WestwickDirector
- Offering amount
- $1.5M
- Amount sold
- $460K
- Minimum investment
- $20K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$280KraisedJan 2023 · 10 investors · PharmaceuticalsRule 506(b)
▶$280KraisedJan 2023 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dan WatkinsExecutive Officer, Director
- Alexander KrupnickExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $280K
- Minimum investment
- $25K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AskY Therapeutics raised?
- AskY Therapeutics has disclosed $740K raised across 2 rounds.
- Where is AskY Therapeutics headquartered?
- AskY Therapeutics is headquartered in Owings Mills, US.